Ir al contenido
HPB-ALL
Pañuelo de papel
Peripheral blood
Enfermedad
Precursor T-cell acute lymphoblastic leukemia
Lugar de metástasis
Peripheral blood (systemic T-ALL)
Sinónimos
HPB/ALL, HPBALL, FCCH1018

Documentos

HPB-ALL

Cell line · Número de producto 302895

HPB-ALL es una línea celular de leucemia linfoblástica aguda de células T precursoras humanas (T-ALL) obtenida a partir de la sangre periférica de un paciente japonés de 14 años...

€430.00sin impuestos ni gastos de envío

Personalización / Recomendaciones

En stock
Lote
Recomendado (lote más fresco)
  • CoA
1

01Información general

Descripción

HPB-ALL is a human precursor T-cell acute lymphoblastic leukemia (T-ALL) cell line established from the peripheral blood of a 14-year-old Japanese male patient. The line grows in suspension with lymphocyte-like morphology. HPB-ALL harbors a complex TP53 mutational profile with eight mutations across heterozygous and homozygous states, reflecting the genetic complexity of T-ALL at diagnosis. The line expresses T cell surface markers consistent with T-ALL biology, making it relevant for studies of T lymphoblast leukemia pathogenesis and drug responses.

HPB-ALL is applicable in studies of T-ALL biology, TP53 multi-mutant phenotype, anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine), Notch and JAK-STAT pathway analysis, and comparative studies within the T-ALL cell line panel. It is suitable for in vitro pharmacological assays and xenograft models in immunocompromised hosts for preclinical T-ALL drug evaluation. Doubling time approximately 50 hours.

Pañuelo de papel
Peripheral blood
Enfermedad
Precursor T-cell acute lymphoblastic leukemia
Lugar de metástasis
Peripheral blood (systemic T-ALL)
Aplicaciones
T-ALL biology; TP53 multi-mutant phenotype; anti-leukemic drug sensitivity (glucocorticoids, vincristine, asparaginase, nelarabine); Notch/JAK-STAT pathways; xenograft models; T-ALL panel comparative studies
Sinónimos
  • HPB/ALL
  • HPBALL
  • FCCH1018

02Clasificación

Organismo
Humano
Sexo
Hombre
Propiedades de crecimiento
Suspensión
Nivel de bioseguridad
1

03Características

Morfología
Lymphoblast-like
Tipo de célula
T-cell
Tiempo de duplicación
~50 hours

04Identificadores

Referencia
HPB-ALL (Cytion catalog number 302895)
N.º de identificación fiscal del NCBI
9606
Cellosaurus
CVCL_1820

05Expresión y susceptibilidad

Perfil mutacional
Mutation: p.Arg465His, Unspecified; Mutation: p.Ala134Ser, Unspecified; Mutation: p.Leu1574Pro, Heterozygous; Mutation: p.Asp2442fs*39, Heterozygous; Mutation: p.Arg159Ser, Unspecified; Mutation: p.Cys124Ter, Homozygous; Mutation: p.Arg273Cys, Unspecified; Mutation: p.Ser121Ter, Unspecified

06Manejo y cultivo

Medio de cultivo
RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
Suplementos
Supplement the medium with 10% FBS
Reactivo de disociación
dilution
Subcultivo
Dilute the culture to 2–5 × 10⁵ cells/ml with fresh pre-warmed complete medium twice per week. No enzymatic dissociation required.
Relación de división
1 : 10 split
Densidad de siembra
3-5*10^5/ml
Renovación de fluidos
Subculture : 2 times/week
Descongelación y cultivo
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

07Control de calidad y criopreservación

Medio de congelación
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Condiciones de almacenamiento

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Condiciones de envío

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

08Donante

Edad del donante
14 years
Origen étnico
Japanese

10Detalles del producto

Tabla de composición